A detailed history of Addison Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Addison Advisors LLC holds 4,379 shares of ABT stock, worth $496,753. This represents 0.15% of its overall portfolio holdings.

Number of Shares
4,379
Previous 4,359 0.46%
Holding current value
$496,753
Previous $452,000 10.4%
% of portfolio
0.15%
Previous 0.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$100.07 - $118.13 $2,001 - $2,362
20 Added 0.46%
4,379 $499,000
Q2 2024

Aug 05, 2024

BUY
$100.73 - $112.44 $27,096 - $30,246
269 Added 6.58%
4,359 $452,000
Q1 2024

May 06, 2024

BUY
$109.52 - $120.96 $29,898 - $33,022
273 Added 7.15%
4,090 $464,000
Q4 2023

Feb 02, 2024

BUY
$90.19 - $110.4 $5,411 - $6,624
60 Added 1.6%
3,817 $420,000
Q2 2023

Aug 03, 2023

SELL
$100.78 - $112.29 $5,039 - $5,614
-50 Reduced 1.31%
3,757 $409,000
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $1,452 - $1,710
15 Added 0.4%
3,807 $385,000
Q4 2022

Feb 07, 2023

SELL
$95.06 - $111.52 $116,828 - $137,058
-1,229 Reduced 24.48%
3,792 $416,000
Q3 2022

Oct 28, 2022

BUY
$96.76 - $112.03 $19,835 - $22,966
205 Added 4.26%
5,021 $486,000
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $510 - $616
-5 Reduced 0.1%
4,816 $523,000
Q1 2022

Apr 29, 2022

BUY
$114.02 - $139.04 $118,808 - $144,879
1,042 Added 27.57%
4,821 $571,000
Q4 2021

Jan 31, 2022

BUY
$115.53 - $141.46 $14,903 - $18,248
129 Added 3.53%
3,779 $532,000
Q2 2021

Jul 29, 2021

SELL
$105.79 - $124.53 $28,563 - $33,623
-270 Reduced 6.89%
3,650 $423,000
Q4 2020

Feb 02, 2021

BUY
$105.0 - $114.42 $411,600 - $448,526
3,920 New
3,920 $429,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Addison Advisors LLC Portfolio

Follow Addison Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Addison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Addison Advisors LLC with notifications on news.